Exclusivity Patents and exclusivity Drug Information Prescribing and other information DMFs Type 2 master files Databases Free access to database search 21 CFR FDA regulations for this API Federal Register FR search results for this API Drug Recalls For Rx's using this API

FDA Approval Activities for this Drug… Coreg (carvedilol) Tablets, 3.125, 6.25, 12.5 and 25 mg GlaxoSmithKline NDA 20297/S011 9/29/03 9/30/03 Coreg (Carvedilol) Tablets, 3.125mg, 6.25mg, 12.5mg, & 25mg. GlaxoSmithKline NDA 20297/S009 3/27/03 4/1/03 7/8/03 Coreg (Carvedilol) Tablets, 3.125mg, 6.25mg, 12.5mg, & 25mg. GlaxoSmithKline NDA 20297/S007 11/1/01 3/28/02 3/28/02 3/28/02 Coreg (Carvedilol) Tablets, 3.125mg, 6.25mg, 12.5mg, & 25mg. SmithKline Beecham NDA 20297/S004 Carvedilol Tablets, TEVA Pharmaceuticals | Carvedilol Tablet, Ranbaxy, Tentative Approval | Coreg (carvedilol) Tablets, GlaxoSmithKline, New or Modified Indication | Coreg (carvedilol) Tablets, SmithKline Beecham, Labeling Revision | Carvedilol Tablets, Caraco Pharma, Tentative Approval | Carvedilol Tablets, Watson Labs, Tentative Approval | Carvedilol Tablets, Caraco Pharma, Tentative Approval | Carvedilol Tablets, Mylan Pharma, Tentative Approval | Carvedilol Tablets, Zydus Pharma, Tentative Approval | Carvedilol Tablets, Taro Pharma, Tentative Approval | Coreg Tablet, Glaxosmithkline, Labeling Revision | Coreg (carvedilol) Tablets, GlaxoSmithKline, Labeling Revision | Coreg CR (carvedilol phosphate) Extended-Release Capsules, GlaxoSmithKline, Approval | Carvedilol Tablets, Hikma Pharma, Tentative Approval | Coreg (carvedilol) Tablets, GlaxoSmithKline, Labeling Revision | Coreg (carvedilol) Tablets, GlaxoSmithKline, Patient Population Altered Check the most up-to-date list of FDA Approvals.                                                                                      A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | FindingHealthOnline © 2009 Betterchem.com